Kimberly-Clark, which owns brands like Kleenex and Huggies, is set to acquire Kenvue, the consumer health company that owns Tylenol, through an almost $49 billion deal. The deal comes after Kenvue faced financial and legal struggles—even parting ways with its CEO in July after its stock sharply dropped—thanks to U.S. Health and Human Services Secretary Robert F. Kennedy Jr. and President Donald Trump’s claims that pregnant women ingesting Tylenol increased the risk of autism for their children—opinions that angered many doctors. A few days ago, Kennedy admitted there wasn’t “sufficient” evidence that proved Tylenol caused autism, although he held fast in his repeated claims that there’s a “very suggestive” link between Tylenol and autism without backing it up factually. Kimberly-Clark’s Ch

See Full Page